Effects of Backward Gait on Sand on Improving the Gait Parameters of Patients With Chronic Stroke.

Effects of Backward Gait on Sand on Improving the Gait Parameters of Patients With Chronic Stroke: a Randomized Controlled Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03501186

Enrollment

Registered

2018-04-18

Start date

2017-01-12

Completion date

2018-07-21

Last updated

2018-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke

Keywords

Backward walking, stroke, gait training

Brief summary

Gait training in stroke is a complex process of motor learning although restoring patients ability to walk would not prepare the individual with the challenges faced in the real environment. The aim is not simply walking in controlled environment, but to achieve dynamic walking. Dynamic walking is the ability of an individual to adjust to the changing surfaces and terrains. thereby returning to achieve active participation in the community. Hence, recovery of walking ability is the primary goal when planning treatment for patients with stroke.

Interventions

OTHERBackward walking on sand

the patient will be walking backwards on sand with therapist standing close to support in case of fall.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

The treatment given by investigator unaware of allocation of patients and outcome variables measured by different investigator

Eligibility

Sex/Gender

ALL

Age

45 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Had experienced stroke for the first time. * Unilateral involvement. * Demonstrate motor stage 3 or 4 on Brunnstrom motor recovery. * Able to walk 12 m with or without assistive devices. * Medically stable. * Able to follow simple commands.

Exclusion criteria

* Patient exhibits comorbid disease other than stroke that may affect gait. * Any conditions contra indicated to exercises * Any other cardio-pulmonary or orthopedic disorders that affects walking ability of the participant.

Design outcomes

Primary

Measure	Time frame	Description
Gait velocity (m/s)	10-15 mins	Measured by Stride Analyser
Cadence (Number of steps per min)	10-15 mins	Measured by stride Analyser
Stride length in meters	10-15 mins	Measured by stride Analyser
Gait cycle in seconds	10-15 mins	Measured by stride Analyser

Secondary

Measure	Time frame	Description
Barthel index	45 Mins	ADL

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026